Philippe LaChapelle, Meina Li, Jo Douglass, Alastair Stewart. (2018).
Safer approaches to therapeutic modulation of TGF-beta signaling for respiratory disease. Pharmacology and Therapeutics.
Christine R. Keenan, Shenna Y. Langenbach, Fernando RJ Guzman, Jade Jaffar, Danica Radojicic, Trudi Harris, Michael J. Schuliga, Glen Westall, Alastair G. Stewart. (2018).
Novel anti-fibrotic effects of casein kinase 1δ/ε inhibitor PF670462.
Frontiers in Translational Pharmacology.
S. Salem, T. Harris, J. Mok Shiueh Lian, M. Yuen Sin Li, C.R. Keenan, M.J. Schuliga, and A.G. Stewart (2012).
Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.
Keenan, CR., Mok, J.S.L., Harris, T., Xia, Y., Salem, S. and Stewart, A.G. (2014).
Bronchial epithelial cells are rendered insensitive to glucocorticoid transactivation by Transforming growth factor-b.
Alastair G Stewart, Belinda Thomas, Jon Koff (2018).
TGF-β: Master regulator of inflammation and fibrosis.
Respirology.
Meina Li, Christine R. Keenan, Guillermo Lopez-Campos, Jonathan E. Mangum, Qianyu Chen, Danica Prodanovic, Yuxiu C. Xia, Shenna Y. Langenbach, Trudi Harris, Vinzenz Hofferek, Gavin E. Reid, Alastair G. Stewart. (2019).
Cofilin1 phosphorylation: a novel non-canonical pathway with potential for safer modulation of TGF-b1 in airways disease.
iScience
Stewart, A.G. (2019).
Engineering drug discovery technologies: clinical trial on-a-chip.
Current Opinion in Pharmacology, 48:13.
Jean-Michel Fustin, Meina Li, Bryan Gao,
Qianyu Chen, Tianhong Cheng, Alastair G. Stewart. (2019).
Rhythm on a chip: circadian entrainment in vitro is the next frontier in body on-a chip technology. Current Opinion in Pharmacology. 48:127-136.
For information on TianLi Biotech and the company development program please contact us via:
info@tlbiotech.com.au
© Copyright 2023 -
TianLi Biotech
Website designed by
Fifth Castle Media